Heyholder
‹ Activism Filings

Penetrium Bioscience Inc. Hyundai Bioscience group changes share pledges; pledged shares now 12,850,000

Penetrium Bioscience Inc.· Report on Large Shareholdings

AI summary · Not investment advice

HYUNDAI BIOSCIENCE CO., LTD.'s group stake in Penetrium Bioscience Inc. stays at 37.57%, while shares under pledge contracts changed from 13,070,000 to 12,850,000.

Total under contracts

12,850,000 shares

20.09%; previously 13,070,000 shares (20.43%)

Key facts

Stake
37.57%Unchanged; Hyundai Bioscience itself holds 16,626,772 shares (25.99%)
Reporting holder
HYUNDAI BIOSCIENCE CO., LTD. and 4 related parties
Previous stake
37.57%
Purpose of holding
Influence over management
Relationship with issuer
Largest shareholder
Report type
Change in contract terms
Reason for report
Change to share pledge contracts
Shares held
24,030,335 sharesUnchanged
Previous shares under major contracts
13,070,000 shares20.43%
Shares under major contracts
12,850,000 shares20.09%
Reporting obligation date
Sep 21, 2026

Commentary

AI commentary · Not investment advice

What happened

The stake of Penetrium Bioscience's largest shareholder, Hyundai Bioscience, and four related parties stays at 37.57%. But its share pledge contracts, where shares are put up as loan collateral, changed. Shares under these contracts went from 13,070,000 to 12,850,000. The filing does not say which contract changed.

In the company's terms

Penetrium Bioscience has 63,966,253 voting shares outstanding. Pledged shares went from 20.43% to 20.09% of them. The largest contract pledges 9,000,000 shares held by Hyundai Bioscience to secure payments on its 11th convertible bonds. An affiliate pledged shares for loans from a card company and several savings banks. Their interest rates are 10.0% to 12.0%, with collateral maintenance ratios of 160% to 200%.

What changes for shareholders

The nearest maturity is 2026.12.07 for a savings bank loan. Two more savings bank loans end on 2026.12.17. Some of the affiliate's loans are also secured by Hyundai Bioscience shares.

Comments

No comments yet

Comments from shareholders will appear here.